Homocysteine enhances clot-promoting activity of endothelial cells via phosphatidylserine externalization and microparticles formation

Amino Acids
Jiuxin ZhuYanjie Lu


Total elevated plasma homocysteine (Hcy) is a risk factor for thromboembolism. Vascular endothelium is important to regulate coagulation, but the impact of Hcy on the clot-promoting activity (CPA) of endothelial cells has not been fully understood. In our study, human umbilical vein endothelial cells (HUVECs) were treated with Hcy (8, 20, 80, 200, 800 μmol/L) for 24 h. Annexin V was utilized to detect phosphatidylserine (PS) externalization and endothelial microparticles (MPs) formation. CPA was assessed by recalcification time and purified clotting complex tests. We found that Hcy enhanced the externalized PS and consequent CPA of HUVECs in a dose-dependent fashion, effect of Hcy had statistical significance at 800 μmol/L. In addition, Hcy also increased the shedding of procoagulant endothelial MPs. Blocking of PS with 128 nmol/L annexin V reduced approximately 70% CPA of HUVECs and endothelial MPs, but human anti-tissue factor antibody had little inhibitive effect. Our results showed that Hcy increased CPA of HUVECs via PS externalization and MPs release. Our present study has implications for hyperhomocysteinemia-related hypercoagulability.


Aug 15, 2014·Critical Reviews in Food Science and Nutrition·Javier Delgado-ListaJose Lopez-Miranda
Aug 16, 2018·American Journal of Physiology. Renal Physiology·Nima AbbasianAlan Bevington


Dec 1, 1991·The Journal of Clinical Investigation·Steven R Lentz, J E Sadler
Jun 1, 1986·The Journal of Clinical Investigation·G M Rodgers, W H Kane
Sep 1, 1993·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·R H FryerG M Rodgers
May 23, 1998·The Journal of Biological Chemistry·Katherine A HajjarB T Chait
Aug 26, 1998·Journal of Structural Biology·I ReviakineA Brisson
Jul 7, 1999·The Journal of Clinical Investigation·V CombesFrançoise Dignat-George
Aug 7, 1999·Lancet·G J Hankey, J W Eikelboom
Jul 20, 2000·European Heart Journal·J Thambyrajah, J N Townend
Mar 21, 2001·Apoptosis : an International Journal on Programmed Cell Death·P MerciéF Belloc
May 1, 2004·Hypertension·Toshimitsu SuharaToshio Ogihara
May 3, 2005·Journal of the American College of Cardiology·Julio A ChirinosYeon S Ahn
Jan 7, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Ronald R Bach
Apr 1, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Anetta UndasHieronim Jakubowski
Nov 23, 2006·Blood Reviews·Andrea PiccinOwen P Smith
Nov 24, 2006·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Jialan ShiGary E Gilbert
Feb 8, 2007·Amino Acids·J Perła-KajánHieronim Jakubowski
Nov 10, 2007·The American Journal of Clinical Nutrition·Kilmer S McCully
Mar 4, 2008·Methods : a Companion to Methods in Enzymology·Gabriela BrumattiSeamus J Martin
Aug 19, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hieronim JakubowskiKevin A Strauss
Nov 8, 2008·Cell and Tissue Research·Gilles N ChironiAlain Tedgui
Dec 27, 2008·Toxicology·Benzhi CaiBaofeng Yang
May 1, 2009·Thrombosis and Haemostasis·Jin ZhouJialan Shi
Jul 14, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Saulius ButenasKenneth G Mann
Oct 21, 2009·The Journal of Clinical Investigation·Andrew T JacovinaKatherine A Hajjar
Jan 28, 2010·Journal of Thrombosis and Haemostasis : JTH·J ZhouGary E Gilbert
Feb 15, 2011·Thrombosis Research·Derrick L SaulsMaureane Hoffman

Related Concepts

Thrombin Time Assay
Annexin A5
Apoptosis, Intrinsic Pathway
Human Umbilical Vein Endothelial Cells
Blood Clot

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.